Robert (Max) Johnston Purchases 85,714 Shares of INOVIQ (ASX:IIQ) Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston bought 85,714 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was purchased at an average cost of A$0.35 per share, for a total transaction of A$29,999.90.

INOVIQ Stock Performance

The firm has a market capitalization of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04. The company has a quick ratio of 9.52, a current ratio of 7.07 and a debt-to-equity ratio of 2.02.

INOVIQ Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.